Alpha Tau Corp (DRTS) Forward Price-to-Revenue Multiple

Public company logo of Alpha Tau Medical Ltd. (DRTS)

The complex transportation of radioactive systems requires specialized protection, which distinguishes Alpha Tau Medical Ltd. (DRTS) in the market. The forward P/S history on the GURU.Markets chart demonstrates resilience, where the level reflects the current magnitude. Growth is based on the implementation of Alpha DaRT technology in clinics and strict compliance with nuclear regulations regarding hazardous waste disposal.

DRTS Alpha Tau Medical: Market Cap to Future Revenue Ratio in the range 07/04/2022 - 11/14/2026

Summary analytical data breakdowns for alphatau.com (DRTS)

- market price and analyst price targets:
Price Chart Alpha Tau Corp|DRTS - Analyst Median Target
- market capitalization details:
Market Valuation Alpha Tau Medical Ltd|DRTS - Value Adjusted for Debt and Cash
- business book valuation details:
Net Assets per Single Share Alpha Tau Medical|DRTS - Total Stockholders' Equity|Market Value to Book Value Ratio alphatau.com|DRTS - Total Business Assets
- debt and solvency information:
Total Debt to Capital Alpha Tau Medical Ltd.|DRTS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Alpha Tau Corp|DRTS - Company Cumulative Debt|Debt to Book Capitalization Ratio Alpha Tau Medical Ltd.|DRTS - Company Long-Term Debt|Company Short-Term Debt Alpha Tau Medical|Quick Ratio alphatau.com
- business earnings and investment ratios data:
DRTS - Annual Net Income|Future Profit Alpha Tau Medical Ltd.|DRTS - Market Cap to Earnings|Forward P/E Multiple Alpha Tau Corp|DRTS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alpha Tau Medical Ltd.|DRTS - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Alpha Tau Medical|DRTS - Earnings per one share for the last 12 months|Quarterly EPS earnings growth alphatau.com|DRTS - Earnings per share increase in current year|Earnings growth forecast for next year Alpha Tau Medical Ltd.
- revenue and sales details:
DRTS - Revenue and Sales Volume|Company Future Sales Volume Alpha Tau|DRTS - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Alpha Tau Corp
Initial company analysis:DRTS (Alpha Tau)
Product sample of Alpha Tau Medical Ltd.

The high scientific authority of Alpha Tau Medical Ltd. (DRTS) in treating solid tumors using Alpha DaRT technology is driving inflated market expectations for future cash flows. The projected P/S metric compares current market capitalization with expected sales volume, allowing for an assessment of the degree of market optimism and the risk of asset overvaluation should monetary policy conditions shift.

Who Alpha Tau Medical Ltd. competes with

Price-to-Projected Revenue Ratio Novocure NVCR|Market Cap to Expected Sales Ratio Fortress Biotech, Inc. (FBIO)|ACRV: Forward Price-to-Revenue Multiple|Forward Price to Sales ALLR (Allarity Therapeutics, Inc.)